Asthma trials recruiting in Arizona

All Asthma trials nationally

Cities in Arizona

Recruiting trials in Arizona

• A Clinical Trial of Soluble Fiber for Asthma
  NCT06372249 · Phase: Phase 2 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Arizona: Phoenix
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Arizona: Phoenix, Tucson
• A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
  NCT07556159 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · Arizona: Chandler, Mesa, Sun City
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
  NCT05757102 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Arizona: Paradise Valley
• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
  NCT07219173 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Tempe
• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
  NCT06023589 · Phase: Phase 3 · Ages: 5 Years to 11 Years · Sex: All (male and female) · Arizona: Phoenix
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Arizona: Chandler
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Arizona: Gilbert, Phoenix
• Evaluation of the Medentum Diagnostik Platform for Pediatric ENT Conditions and Asthma
  NCT07500532 · Phase: Not applicable (e.g. observational or device study) · Ages: 3 Years to 17 Years · Sex: All (male and female) · Arizona: Tuscon
• Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
  NCT06385236 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Scottsdale
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Arizona: Phoenix
• Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma
  NCT07665892 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Arizona: Glendale
• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
  NCT06750289 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · Arizona: Chandler, Sun City, Tucson